Donor and recipient risk factors and choice of immunosuppression determine long-term outcome in renal transplantation

Transplant Proc. 2001 Nov-Dec;33(7-8):3400-2. doi: 10.1016/s0041-1345(01)02465-4.

Authors

T H Mathew¹, S P McDonald, G R Russ

Affiliation

¹ ANZDATA & ANZOD Registries and the Renal Unit, The Queen Elizabeth Hospital, Woodville, South Australia, Australia.

PMID: 11750455
DOI: 10.1016/s0041-1345(01)02465-4

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Age Factors
Australia
Cyclosporine / therapeutic use
Graft Survival / physiology*
Humans
Immunosuppression Therapy / methods*
Immunosuppressive Agents / therapeutic use
Kidney Transplantation / mortality
Kidney Transplantation / physiology*
Living Donors*
Middle Aged
Multivariate Analysis
New Zealand
Registries
Regression Analysis
Risk Factors
Survival Rate
Time Factors
Tissue Donors*
Treatment Outcome

Substances

Immunosuppressive Agents
Cyclosporine